The Patent Finder

Abcellera Biologics Inc.

Also on record
Records under this name other than the patents Abcellera Biologics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 8 of 8 · Back to Abcellera Biologics Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,400,281Methods for Determining Lymphocyte Receptor Chain Pairs
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,460,318Methods for Determining Lymphocyte Receptor Chain Pairs
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,371,166Methods for Determining Lymphocyte Receptor Chain Pairs
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,725,052ANTI-PAR-2 Antibodies and Methods of Use Thereof
Held by another company
In force
 · High confidence
In forceHigh confidence
US 12,384,841ANTI-PAR-2 Antibodies and Methods of Use Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,240,902ANTI-TREM2 Antibodies and Methods of Use Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,447,541Anti-Coronavirus Antibodies and Methods of Use
Lapsed on the fee record
Ended Sep 20, 2026 · Low confidence
Lapsed on the fee recordEnded Sep 20, 2026Low confidence
US 11,370,828Anti-Coronavirus Antibodies and Methods of Use
Lapsed on the fee record
Ended Jun 28, 2026 · Medium confidence
Lapsed on the fee recordEnded Jun 28, 2026Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited